These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 25252209)

  • 1. Severe autogenously fecal peritonitis in ageing Wistar rats. Response to intravenous meropenem.
    Mascena GV; Melo MC; Gadelha DN; Oliveira TK; Brandt CT
    Acta Cir Bras; 2014 Sep; 29(9):615-21. PubMed ID: 25252209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe autogenously fecal peritonitis in Wistar rats with permanent bilateral carotid occlusion. Response to intra peritoneal moxifloxacin combined with dexamethasone.
    Melo MC; Gadelha DN; Oliveira TK; Brandt CT
    Acta Cir Bras; 2014 Feb; 29(2):76-81. PubMed ID: 24604309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol extract of Schinu sterebinthifolius raddi (anacardiaceae) as a local antimicrobial agent in severe autogenously fecal peritonitis in rats.
    Melo MC; Gadelha DN; Oliveira TK; Brandt CT
    Acta Cir Bras; 2014; 29 Suppl 1():52-6. PubMed ID: 25185057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal peritonitis in aging rat model. Therapeutic response to different antibiotic strategies.
    Mascena GV; Figueiredo Filho CA; Lima Júnior MAX; Oliveira TKB; Gadelha DNB; Melo MCSC; Brandt CT
    Acta Cir Bras; 2018 May; 33(5):446-453. PubMed ID: 29924208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain damage and congenital cataract due to autogenously fecal peritonitis in pregnant Wistar rats.
    Brandt CT; Melo MC; Gadelha DN; Gadelha NN; Oliveira TK; Falcão MP
    Acta Cir Bras; 2014 Oct; 29(10):681-7. PubMed ID: 25318001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.
    Brunkhorst FM; Oppert M; Marx G; Bloos F; Ludewig K; Putensen C; Nierhaus A; Jaschinski U; Meier-Hellmann A; Weyland A; Gründling M; Moerer O; Riessen R; Seibel A; Ragaller M; Büchler MW; John S; Bach F; Spies C; Reill L; Fritz H; Kiehntopf M; Kuhnt E; Bogatsch H; Engel C; Loeffler M; Kollef MH; Reinhart K; Welte T;
    JAMA; 2012 Jun; 307(22):2390-9. PubMed ID: 22692171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autogenous fecal peritonitis in Wistar rats with permanent bilateral carotid occlusion: morbidity, mortality and microbiological response.
    Gadelha DN; Melo MC; Oliveira TK; Brandt CT
    Acta Cir Bras; 2013 Apr; 28(4):299-306. PubMed ID: 23568238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological features of peritoneal lavage with ropivacaine in rats with fecal peritonitis.
    Brocco MC; Gomez RS; Paulo DN; Almeida CE; Baptista JF
    Acta Cir Bras; 2012 Feb; 27(2):193-9. PubMed ID: 22378377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copaiba oil effect on induced fecal peritonitis in rats.
    Lopes LN; Santos FA; Oliveira LC; Percário S; Barros CA; Brito MV
    Acta Cir Bras; 2015 Aug; 30(8):568-73. PubMed ID: 26352337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intravenous gamma immunoglobulins treatment on severe peritonitis in rats.
    Greenberg R; Haddad R; Kashtan H; Skornick Y; Kaplan O
    Int J Surg Investig; 2001; 2(6):433-42. PubMed ID: 12678124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of peritoneal reinfection after fecal peritonitis.
    Alberti LR; Petroianu A
    Acta Cir Bras; 2012 Sep; 27(9):630-3. PubMed ID: 22936088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem monotherapy versus cefotaxime plus metronidazole combination treatment for serious intra-abdominal infections.
    Kempf P; Bauernfeind A; Müller A; Blum J
    Infection; 1996; 24(6):473-9. PubMed ID: 9007598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study.
    Zhao HY; Gu J; Lyu J; Liu D; Wang YT; Liu F; Zhu FX; An YZ
    Chin Med J (Engl); 2017 May; 130(10):1139-1145. PubMed ID: 28485312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial.
    Piano S; Fasolato S; Salinas F; Romano A; Tonon M; Morando F; Cavallin M; Gola E; Sticca A; Loregian A; Palù G; Zanus G; Senzolo M; Burra P; Cillo U; Angeli P
    Hepatology; 2016 Apr; 63(4):1299-309. PubMed ID: 26084406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutical and inflammatory response in rats with secondary peritonitis and topical use of ampicilin/sulbactam].
    Kreimer F; Aguiar JL; Castro CM; Lacerda CM; Reis T; Lisboa Júnior F
    Acta Cir Bras; 2005; 20 Suppl 1():63-71. PubMed ID: 16186973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Auto-cross-linked hyaluronic acid gel does not reduce intra-abdominal adhesions or abscess formation in a rat model of peritonitis.
    Sikkink CJ; de Man B; Bleichrodt RP; van Goor H
    J Surg Res; 2006 Dec; 136(2):255-9. PubMed ID: 17059836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meropenem versus imipenem/cilastatin in the treatment of intraabdominal infections requiring surgery.
    Kanellakopoulou K; Giamarellou H; Papadothomakos P; Tsipras H; Chloroyiannis J; Theakou R; Sfikakis P
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):449-53. PubMed ID: 8359165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
    Colardyn F; Faulkner KL
    J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
    Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
    Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model.
    Tsao CM; Li KY; Chen SJ; Ka SM; Liaw WJ; Huang HC; Wu CC
    Crit Care; 2014 Nov; 18(6):652. PubMed ID: 25432865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.